CFOs On the Move: Week Ending July 22

The Coca-Cola Company, MariaDB, Vistra, Kirkland’s, Evelo Biosciences, Dynex Capital, Hammitt, Ra Medical Systems

  John Murphy

John Murphy | The Coca-Cola Company

John Murphy, CFO and executive vice president of the Coca-Cola Company, will take on the additional role of president. Murphy began his career at the beverage company in 1988 as an international internal auditor and has held a variety of general management, finance, and strategic planning roles around the world. He has been CFO since 2019. Murphy takes over for Brian Smith, who is retiring. Smith will remain with the company as a senior executive through February 2023.

Christine Napoli  | MariaDB

Cloud database company MariaDB hired Christine Napoli as CFO ahead of becoming a public company through a special-purpose acquisition company (SPAC) merger. Napoli joins the company from NBCUniversal, where she has worked for 25 years. Most recently, she was CFO of NBCUniversal’s streaming service Peacock. While at Peacock, she helped to grow the business to 28 million monthly active accounts in a two-year period and well over $700 million in fiscal year revenue. 

  Kris Moldovan

Kris Moldovan  | Vistra

Kris Moldovan was promoted to chief financial officer of Vistra. Moldovan has worked at the electricity and power generation company and its predecessor companies since 2006. For the past five years, he has been senior vice president and treasurer. Moldovan originally joined the company as senior counsel, where much of his work focused on finance and mergers and acquisitions. Before joining Vistra, he was an attorney for Gibson, Dunn & Crutcher in Dallas and for Wildman, Harrold, Allen & Dixon in Chicago. 

Nicole Strain | Kirkland’s

Nicole Strain is stepping down as finance chief and chief operations officer of home furnishings retailer Kirkland’s. Strain joined the company as controller in 2016 and was promoted to CFO in 2019. She took on the additional role of chief operations officer in February. While the retailer looks for her successor, it will rely on a newly-established office of the CFO, which will be co-led by company controller Anna Wilhoit and senior director of FP&A Jessica Tatum. 

  Marella Thorell

Marella Thorell  | Evelo Biosciences

Evelo Biosciences hired Marella Thorell as CFO. Thorell joins the biotechnology company from Centessa Pharmaceuticals, where she was most recently chief accounting officer and previously held the title of head of finance. Thorell was previously chief financial officer of Palladio Biosciences before its acquisition by Centessa. Before that, she spent over 10 years at Realm Therapeutics in various roles, including chief financial officer and chief operating officer. 

Robert Colligan | Dynex Capital

Robert Colligan was appointed chief financial officer of Dynex Capital. Colligan joins the financial services company from real estate investment trust Chimera Investment, where he held the same role. Colligan was previously controller at Starwood Capital Group. Earlier in his career, he worked for Merrill Lynch and Bear Stearns on financial reporting, strategy, and investor relations matters. Colligan replaces Stephen Benedetti, who is leaving the company after 28 years. Benedetti has been CFO since 2008. 

Ryan Meyer

Ryan Meyer | Hammitt

Luxury handbag retailer Hammitt hired Ryan Meyer as finance chief. Meyer was most recently executive vice president and CFO of women’s fashion and apparel brand The GREAT. He previously was the head of finance for casual apparel brand Buck Mason. He also held the chief operating officer and head of finance positions at Boatbound, a boat rental platform, as well as CFO at yoga and accessories brand Manduka. 

Brian Conn | Ra Medical Systems

Ra Medical Systems named Brian Conn as interim chief financial officer. Conn has served as a consultant to Ra Medical since May. Conn was previously CFO of genomic sequencing startup Quantapore, where he continues to serve as an adviser. He was previously CFO of preclinical medical imaging company Imagion Biosystems Limited and biotechnology company Verdezyne. Will McGuire, Ra’s CEO and a company director, has been interim CFO since July 8 following the departure of CFO Andrew Jackson.